A study found that using heart scans to guide statin prescriptions produces risk assessments similar to traditional methods but triples patient adherence.

"Heart-scan statin guidance matches traditional risk scores with triple the adherence" — Science Daily (all) · Science & Medicine

6 Nov 2026

View source

What it means

This is a randomized trial, CorCal Outcomes, comparing two ways to decide who should take a for primary prevention: a coronary artery calcium (CAC) versus the traditional pooled cohort equation (PCE) risk calculator. The scan-based approach produced risk assessments similar to the traditional method and no difference in major cardiovascular events, but patient to statins was roughly three times higher—likely because seeing actual calcified plaque makes the risk feel more tangible.

Accuracy & sourcesGrounded

The claim is solid as a reputable secondary report of a named primary source: the CorCal Outcomes randomized trial, whose abstract appears in the American Heart Journal (via ScienceDirect). The headline's two claims—similar risk assessments and tripled adherence—are fair summaries of the trial's reported findings, though 'triple the adherence' is a compressed way of stating the adherence outcome.

A study found that using heart scans to guide statin prescriptions produces risk assessments similar to traditional methods but triples patient adherence.

What it means

Accuracy & sourcesGrounded

How new

Go deeper